These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23033557)

  • 1. Does PSA testing hurt or help?
    Johns Hopkins Med Lett Health After 50; 2012 Aug; 24(7):6. PubMed ID: 23033557
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen: a new(ish) study.
    Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
    [No Abstract]   [Full Text] [Related]  

  • 3. The new PSA report: understand the controversy.
    Harv Mens Health Watch; 2012 Feb; 16(7):1-4. PubMed ID: 22474703
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early detection of prostatic carcinoma: Is PSA screening suitable?].
    Kaulen H
    Dtsch Med Wochenschr; 2003 May; 128(18):977. PubMed ID: 12755136
    [No Abstract]   [Full Text] [Related]  

  • 5. European PSA testing trial update offers little guidance to American men.
    Harv Mens Health Watch; 2012 Jun; 16(11):8. PubMed ID: 22768409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
    Urologiia; 2001; (2):37-40. PubMed ID: 11490716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA scores: should we use a lower threshold?
    Carter HB
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.
    Hillenbrand M; Bastian M; Steiner M; Zingler C; Müller M; Wolff JM; Seiter H; Schuff-Werner P
    Anticancer Res; 2000; 20(6D):4995-6. PubMed ID: 11326656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
    Yesner R; Kelly LJ; Chan YK
    Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.
    Froehner M; Hakenberg OW; Koch R; Schmidt U; Meye A; Wirth MP
    Urol Int; 2006; 76(1):27-30. PubMed ID: 16401917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate tissue and serum markers.
    Mazzucchelli R; Colanzi P; Pomante R; Muzzonigro G; Montironi R
    Adv Clin Path; 2000 Jul; 4(3):111-20. PubMed ID: 11080790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The usefulness of prostate-specific antigen assay for the early detection and follow up of the prostate cancer].
    Saito Y
    Nihon Rinsho; 1998 Aug; 56(8):1989-93. PubMed ID: 9750493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.
    Filella X; Truan D; Alcover J; Quintó L; Molina R; Luque P; Coca F; Ballesta AM
    Urology; 2004 Jun; 63(6):1100-3; discussion 1103-4. PubMed ID: 15183958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].
    Pushkar' DIu; Rasner PI; Skobelev PP
    Urologiia; 2001; (6):48-54. PubMed ID: 11785083
    [No Abstract]   [Full Text] [Related]  

  • 15. The PSA revisited: potentials and pitfalls.
    Harv Mens Health Watch; 1999 Jun; 3(11):1-5. PubMed ID: 10233802
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study supports PSA velocity risk count.
    Fillon M
    J Natl Cancer Inst; 2012 Jul; 104(14):1042-3. PubMed ID: 22781432
    [No Abstract]   [Full Text] [Related]  

  • 18. PSA quo vadis? It is reasonable to start with prostate-specific antigen testing at the age of 40!
    Börgermann C; vom Dorp F; Swoboda A; Ketteniss O; Becker M; Rübben H
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1190-5. PubMed ID: 21447776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
    Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro PSA : a "pro cancer" form of PSA?
    Peyromaure M; Fulla Y; Debré B; Dinh-Xuan AT
    Med Hypotheses; 2005; 64(1):92-5. PubMed ID: 15533620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.